Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Epizyme Inc (NQ: EPZM ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Aug 11, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Epizyme Inc < Previous 1 2 3 4 Next > Epizyme: Q2 Earnings Insights August 09, 2022 Epizyme (NASDAQ:EPZM) reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2022 June 28, 2022 Upgrades Via Benzinga The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies June 27, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Why Is Epizyme (EPZM) Stock Up 75% Today? June 27, 2022 EPZM stock is jumping higher today on news that Epizyme is being acquired by French pharmaceutical company Ipsen. Via InvestorPlace Why Epizyme Shares Are Soaring Today June 27, 2022 Epizyme Inc (NASDAQ: EPZM) shares are trading higher Monday after the company announced it entered into a definitive agreement to be acquired by Ipsen. Via Benzinga This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday June 28, 2022 Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade. Via Benzinga Epizyme: Q1 Earnings Insights May 10, 2022 Epizyme (NASDAQ:EPZM) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Via Benzinga Recap: Epizyme Q4 Earnings March 01, 2022 Epizyme (NASDAQ:EPZM) reported its Q4 earnings results on Tuesday, March 1, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings... Via Benzinga Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session June 27, 2022 Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade. Via Benzinga Axsome Therapeutics (AXSM) Stock Soars on FDA Labeling Proposal June 27, 2022 Axsome Therapeutics (AXSM) stock is rising higher on Monday following an update from the FDA about product labeling for one of its drugs. Via InvestorPlace Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2022 June 27, 2022 Upgrades Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session June 27, 2022 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday June 27, 2022 Good morning, trader! We're starting off the week with an overview of the biggest pre-market stock movers for Monday morning! Via InvestorPlace Ipsen Scoops Up Blood Cancer-Focused Epizyme - Read Why June 27, 2022 Ipsen SA (OTC: IPSEY) has Via Benzinga Epizyme + 20 Stocks Moving In Monday's Pre-Market Session June 27, 2022 Gainers Tenax Therapeutics, Inc. (NASDAQ: TENX) rose 90.1% to $0.59 in pre-market trading after dipping more than 46% on Friday. Via Benzinga 76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More June 23, 2022 Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash. Via Benzinga 40 Stocks Moving In Wednesday's Mid-Day Session June 22, 2022 Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares jumped 116.6% to $12.82 after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash. Via Benzinga 20 Stocks Moving in Tuesday's Pre-Market Session June 14, 2022 Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) rose 48.5% to $2.57 in pre-market trading after the company reached an agreement with Phillip Morris for international electronic nicotine... Via Benzinga 93 Biggest Movers From Yesterday June 14, 2022 Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on Monday after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in... Via Benzinga 91 Biggest Movers From Friday June 13, 2022 Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto. Via Benzinga 44 Stocks Moving In Friday's Mid-Day Session June 10, 2022 Gainers Cogent Biosciences, Inc. (NASDAQ: COGT) shares jumped 77% to $8.79 after the company reported initial data from its ongoing Phase 2 APEX clinical trial. Via Benzinga 25 Stocks Moving in Friday's Pre-Market Session June 10, 2022 Gainers Regis Corporation (NYSE: RGS) rose 74.4% to $0.9753 in pre-market trading. Regis partnered with salon technology provider Zenoti to support its 5,000+ locations. Via Benzinga Epizyme's Return On Capital Employed Insights June 09, 2022 Epizyme (NASDAQ:EPZM) brought in sales totaling $8.70 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 9.58%, resulting in a loss of $55.51 million. Via Benzinga Stocks That Hit 52-Week Lows On Friday May 27, 2022 During Friday's session, 59 stocks hit new 52-week lows. Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session May 16, 2022 Gainers Adaptimmune Therapeutics (NASDAQ:ADAP) stock rose 12.7% to $1.6 during Monday's after-market session. The market value of their outstanding shares is at $258.9 million. Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session May 16, 2022 Via Benzinga 30 Stocks Moving in Monday's Pre-Market Session May 16, 2022 Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) rose 25.2% to $2.09 in pre-market trading after gaining around 10% on Friday. Via Benzinga Epizyme Earnings Preview May 09, 2022 Epizyme (NASDAQ:EPZM) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Epizyme will report... Via Benzinga Epizyme's Return On Capital Employed Insights March 04, 2022 According to Benzinga Pro data, during Q4, Epizyme (NASDAQ:EPZM) posted sales of $11.58 million. Earnings were up 23.06%, but Epizyme still reported an overall loss of $50.65... Via Benzinga 99 Biggest Movers From Yesterday May 12, 2022 Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company. Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.